Key facts
- This page summarizes Christopher Lesovitz's Form 4 filing for STRATA Skin Sciences, Inc. (SSKN).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 22 Nov 2023, 16:04.
Christopher Lesovitz - 22 Nov 2023 Form 4 Insider Report for STRATA Skin Sciences, Inc. (SSKN)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- SSKN
- Reported as of
- 22 Nov 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 22 Nov 2023, 16:04:01 UTC
- Prior SEC filing
- 11 Aug 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher Lesovitz
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Christopher Lesovitz filed Form 4 for STRATA Skin Sciences, Inc. (SSKN) on 22 Nov 2023.
Change
- Previous filing in this sequence was filed on 11 Aug 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SSKN
transaction
Derivative
Employee Stock Option
Award
- Transaction value
- $0
- Shares
- +337,500
- Change %
- +75%
- Price
- $0.000000
- Shares after
- 787,500
- Date
- 21 Nov 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 337,500
- Exercise price
- $0.5000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Options shall vest in twelve equal quarterly amounts over a period of three years from date of grant.